GastroGeniX is a division of Sanovas Incorporated; a Life Science technology company focused on the development and commercialization of a disruptive, leading-edge platform of miniaturized imaging and sensor-based systems. Our systems are designed to operate a new generation of interventional product systems to advance the capabilities of minimally invasive surgery.
Sanovas has developed proprietary technologies for imaging, diagnosis, and treatment including local drug delivery, with broad application across a range of medical and surgical specialties. A focused assessment was undertaken to assess the implementation and impact of these technologies inside anatomical spaces deep inside the gastrointestinal tracts of both human and veterinary patients; how could they be applied, and would those applications provide a significant improvement over currently deployed methods were the fundamental questions driving this effort.
The result has been the signature of a patent license and joint venture Agreement with the University of Saskatchewan for transfer and development of their Intellectual Property into a novel toolset that can change the patient experience. This positive change will enable procedures to take place outside the hospital environment, thereby meeting the needs of more efficient diagnosis, treatment, and cost.
In 2011, GastroGeniX was incorporated to focus on this opportunity worldwide.
The company is based in San Rafael, California.